BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7999812)

  • 1. Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
    Brier ME; Aronoff GR
    Adv Perit Dial; 1994; 10():141-3. PubMed ID: 7999812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
    Hagelskjaer LH; Møller JK
    Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
    Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
    J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gray HH; Goulding S; Eykyn SJ
    Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
    Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
    Benjamin J; Ben-Ezer Gradus D; Mostoslavski M; Rapoport J; Chaimovitz C
    Isr J Med Sci; 1989 Dec; 25(12):699-702. PubMed ID: 2613500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
    Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK; Hagelskjaer LH
    Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
    Horton MW; Deeter RG; Sherman RA
    Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
    Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter peritonitis in patients on CAPD: characteristics and outcome.
    Lye WC; Lee EJ; Ang KK
    Adv Perit Dial; 1991; 7():176-9. PubMed ID: 1680420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
    Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
    Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rare cause of peritoneal dialysis-related peritonitis: Haemophilus influenzae].
    Unal A; Perçin DE; Sipahioğlu MH; Kavuncuoğlu F; Tokgöz B; Oymak O; Utaş C
    Mikrobiyol Bul; 2009 Jul; 43(3):477-80. PubMed ID: 19795624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.
    Innes A; Burden RP; Finch RG; Morgan AG
    Nephrol Dial Transplant; 1994; 9(7):797-9. PubMed ID: 7970121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.
    Parchuri S; Mohan S; Cunha BA
    Heart Lung; 2005; 34(5):360-3. PubMed ID: 16157192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.